-
autoimmunity, leading assay development, primary B-cell models, and autoimmune in vivo models. (CRCI2NA, Translational Onco-haematology): Led by Dr Catherine Pellat, providing expertise in high-risk B-cell
Enter an email to receive alerts for mobile-developer "https:" positions